COVID-19 imaging: Part 3

5th June 2020  13:30 - 16:45 (GMT+01:00) Europe/London

FREE virtual event – Friday 5 June 13:30-16:45 BST

 

Registration

Registration closes on Friday 5 June 2020 at 13:15 hrs. If you are unable to register or attend the live event, the recording will be available on the BIR website on Monday 8 June (pm).

 

Joining the meeting

The meeting room will open on Friday 5 June from 11am.

If you registered on the day you will be able to join the meeting from 12:30 hrs onwards

 

Further updates

Follow us on Twitter @BIR_News or sign up for our email alerts here to get further updates on our educational programmes

 

These are unprecedented times and COVID-19 has impacted all of us in one way or another. This event will look at the impact it has had and continues to have on imaging. 

 

In this third instalment, we will be taking you into the eye of the COVID storm and exploring lessons learnt, both from a radiologist’s and a radiographer’s perspective. 
We will present the CT appearances of severe respiratory failure in COVID and look into how the virus has impacted on oncology outcomes and pathways.

Having looked back, we take a look forward to how we might adapt pathways and training in what could be an uncertain future.

 

View the programme

 

Become a member of the BIR to gain access to hundreds of other webinars and online learning tools for free today!

 

FREE virtual event 

3 CPD points

May help to support outcomes 02. 03. 09. 12. 19. of CPD Now

This image is not available because: You don’t have the privileges to see it, or it has been removed from the system

Venue

Speakers

Sponsors

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Aidence

Aidence rallies the brightest minds in deep learning and radiology to create Veye Chest, an AI-based assistant for lung nodules on chest CT. Cutting through the hype around AI, we bring applications that add value for radiologists. Veye Chest is currently running in Lung Health Checks pilot sites and in routine practice across the UK.

Bayer

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit www.siemens-healthineers.com/en-uk/